Advertisement

Topics

Cruachem Limited Company Profile

00:59 EDT 24th September 2017 | BioPortfolio

Cruachem Ltd, an Annovis Inc. company, is a leader in nucleic acid chemistry. Cruachem offers the largest range of DNA and RNA custom oligonucleotides available including oligomimetics (-molecular mimics used in antisense therapies), as well as DNA and RNA synthesis reagents and molecular biology kits. Our custom oligonucleotides are synthesised using our own high quality phosphoramidites manufactured at our ISO9000 and PSCOP registered facility is Glasgow. We provide products to over 35 countries worldwide, directly or through our network of 20 distributors. Thanks to our vast experience with nucleic acid chemistry, we can also offer contract nucleic acid production services from R & D scale, through scale-up, to Kg scale manufacturing.

Location

United Kingdom


News Articles [13 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

Cruachem Limited

Cruachem Ltd, an Annovis Inc. company, is a leader in nucleic acid chemistry. Cruachem offers the largest range of DNA and RNA custom oligonucleotides available including oligomimetics (-molecular mi...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Transgenomics Incorporated

Cruachem Ltd is a leader in nucleic acid chemistry. We offer custom DNA and RNA oligonucleotides, DNA and RNA synthesis reagents, and contract nucleic acid manufacturing from R & D scale to Kg scale.

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Cruachem Limited" on BioPortfolio

We have published hundreds of Cruachem Limited news stories on BioPortfolio along with dozens of Cruachem Limited Clinical Trials and PubMed Articles about Cruachem Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cruachem Limited Companies in our database. You can also find out about relevant Cruachem Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Antisense therapy
Most human diseases are caused by production of abnormal proteins or malfunctioning proteins.   Antisense therapy involves inhibiting production of these proteins.  When a gene is known to cause a specific disease and the genetic sequence ...


Corporate Database Quicklinks



Searches Linking to this Company Record